Cargando…
Infection on a chip: a microscale platform for simple and sensitive cell-based virus assays
The plaque assay has long served as the “gold standard” to measure virus infectivity and test antiviral drugs, but the assay is labor-intensive, lacks sensitivity, uses excessive reagents, and is hard to automate. Recent modification of the assay to exploit flow-enhanced virus spread with quantitati...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869488/ https://www.ncbi.nlm.nih.gov/pubmed/19142734 http://dx.doi.org/10.1007/s10544-008-9263-7 |
_version_ | 1782181131291983872 |
---|---|
author | Zhu, Ying Warrick, Jay W. Haubert, Kathryn Beebe, David J. Yin, John |
author_facet | Zhu, Ying Warrick, Jay W. Haubert, Kathryn Beebe, David J. Yin, John |
author_sort | Zhu, Ying |
collection | PubMed |
description | The plaque assay has long served as the “gold standard” to measure virus infectivity and test antiviral drugs, but the assay is labor-intensive, lacks sensitivity, uses excessive reagents, and is hard to automate. Recent modification of the assay to exploit flow-enhanced virus spread with quantitative imaging has increased its sensitivity. Here we performed flow-enhanced infection assays in microscale channels, employing passive fluid pumping to inoculate cell monolayers with virus and drive infection spread. Our test of an antiviral drug (5-fluorouracil) against vesicular stomatitis virus infections of BHK cell monolayers yielded a two-fold improvement in sensitivity, relative to the standard assay based on plaque counting. The reduction in scale, simplified fluid handling, image-based quantification, and higher assay sensitivity will enable infection measurements for high-throughput drug screening, sero-conversion testing, and patient-specific diagnosis of viral infections. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10544-008-9263-7) contains supplementary material, which is available to authorized users. |
format | Text |
id | pubmed-2869488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-28694882010-05-14 Infection on a chip: a microscale platform for simple and sensitive cell-based virus assays Zhu, Ying Warrick, Jay W. Haubert, Kathryn Beebe, David J. Yin, John Biomed Microdevices Article The plaque assay has long served as the “gold standard” to measure virus infectivity and test antiviral drugs, but the assay is labor-intensive, lacks sensitivity, uses excessive reagents, and is hard to automate. Recent modification of the assay to exploit flow-enhanced virus spread with quantitative imaging has increased its sensitivity. Here we performed flow-enhanced infection assays in microscale channels, employing passive fluid pumping to inoculate cell monolayers with virus and drive infection spread. Our test of an antiviral drug (5-fluorouracil) against vesicular stomatitis virus infections of BHK cell monolayers yielded a two-fold improvement in sensitivity, relative to the standard assay based on plaque counting. The reduction in scale, simplified fluid handling, image-based quantification, and higher assay sensitivity will enable infection measurements for high-throughput drug screening, sero-conversion testing, and patient-specific diagnosis of viral infections. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10544-008-9263-7) contains supplementary material, which is available to authorized users. Springer US 2009-01-14 2009 /pmc/articles/PMC2869488/ /pubmed/19142734 http://dx.doi.org/10.1007/s10544-008-9263-7 Text en © Springer Science+Business Media, LLC 2008 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Zhu, Ying Warrick, Jay W. Haubert, Kathryn Beebe, David J. Yin, John Infection on a chip: a microscale platform for simple and sensitive cell-based virus assays |
title | Infection on a chip: a microscale platform for simple and sensitive cell-based virus assays |
title_full | Infection on a chip: a microscale platform for simple and sensitive cell-based virus assays |
title_fullStr | Infection on a chip: a microscale platform for simple and sensitive cell-based virus assays |
title_full_unstemmed | Infection on a chip: a microscale platform for simple and sensitive cell-based virus assays |
title_short | Infection on a chip: a microscale platform for simple and sensitive cell-based virus assays |
title_sort | infection on a chip: a microscale platform for simple and sensitive cell-based virus assays |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869488/ https://www.ncbi.nlm.nih.gov/pubmed/19142734 http://dx.doi.org/10.1007/s10544-008-9263-7 |
work_keys_str_mv | AT zhuying infectiononachipamicroscaleplatformforsimpleandsensitivecellbasedvirusassays AT warrickjayw infectiononachipamicroscaleplatformforsimpleandsensitivecellbasedvirusassays AT haubertkathryn infectiononachipamicroscaleplatformforsimpleandsensitivecellbasedvirusassays AT beebedavidj infectiononachipamicroscaleplatformforsimpleandsensitivecellbasedvirusassays AT yinjohn infectiononachipamicroscaleplatformforsimpleandsensitivecellbasedvirusassays |